Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- NCT ID
- NCT07227077
- Registry status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Medical College of Wisconsin
- Conditions
- Bladder Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Lung Cancer, Prostate Cancer
Overview
ClinicalTrials.gov lists this study as Recruiting.
Official title: An Adaptive Design for Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Enrollment: 50 participants (Estimated).
What is being studied
- Behavioral: Physical Activity Promotion Intervention
Who may be eligible
- Ages
- 65 Years to no maximum
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
1 study location is listed.
Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.
Countries: United States
- Wisconsin, United States: 1
Sample of listed locations
- Froedtert Hospital — Milwaukee, Wisconsin, 53226, United States — Recruiting
Study details
- Start date
- February 7, 2026
- Primary completion date
- May 1, 2027
- Completion date
- May 1, 2027
- First posted
- November 12, 2025
- Collaborators
- National Cancer Institute (NCI)
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07227077
- Registry last updated
- August 20, 2026
- QualifiedStudies registry data refreshed
- October 5, 2026
- QualifiedStudies record fetched
- October 5, 2026
View NCT07227077 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Neck Pain studies | Clinical trial FAQ